ASCVD 10-year Risk (PCE)
ASCVD 10-year Risk (PCE) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the ASCVD 10-year Risk (PCE) → Runs in your browser. No signup, no tracking.
What this is
Estimate 10-year atherosclerotic cardiovascular disease risk using the 2013 ACC/AHA Pooled Cohort Equations. Sophie Well takes age, sex, race, total and HDL cholesterol, systolic blood pressure (treated or untreated), diabetes, and smoking, and returns the 10-year ASCVD risk percentage along with the conventional risk band (low/borderline/intermediate/high). PCE retains race-stratified equations. Source: Goff DC Jr et al, Circulation 2014.
When to use it
Use ASCVD for primary-prevention risk stratification in adults 40-79 without existing cardiovascular disease. The result anchors statin and aspirin conversations under current ACC/AHA guidelines. PCE is known to over-estimate in some contemporary cohorts; the newer PREVENT equations (separate tile) drop race and add kidney function and SDoH and may be preferred when validated.
References
Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: Pooled Cohort Equations. Circulation. 2014;129(25 Suppl 2):S49-73. PCE retains race-stratified equations (white vs African-American). Read the source ↗
Worked example: ASCVD PCE ~5-7% 10-year risk (borderline to low risk; race/treated/smoke/dm modifiers shift the band).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.